|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.155
|
Human |
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.122
|
Human |
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.101
|
Human |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.087
|
Human |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.068
|
Human |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.059
|
Human |
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.035
|
Human |
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.032
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.032
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.032
|
Human |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.031
|
Human |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
Human |
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.028
|
Human |
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
Human |
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.026
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
Human |
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
Human |
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
Human |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.019
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.018
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.017
|
Human |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.016
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.015
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.015
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.015
|
Human |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.015
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.014
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.013
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.013
|
|
|
|
g0 to g1 transition
|
GO:0045023 |
3 |
0.013
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.013
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.013
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.012
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.012
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.012
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.012
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
Human |
|
|
lipid storage
|
GO:0019915 |
36 |
0.011
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.011
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.011
|
Human |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.011
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.011
|
Human |
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.010
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.010
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.010
|
Human |
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.010
|
|